WCN26-4643 Infertility Risk with Cyclophosphamide in Lupus Nephritis: A Multi-Center Real-World Experience from Saudi Arabia

Read full text Summarise with VIRAT
Authors: Ghada Ankawi, Rehab B. Albakr, Raghad Alsaaedi, Naurin Naim, Sarah Dahlan, Tofol AlNashmi, Abdulkareem Alsuwaida
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cyclophosphamide (CYC) is an effective treatment for lupus nephritis but is associated with a risk of infertility, which limits its use in women of reproductive age. This study aims to describe a multi-center experience with CYC use and its impact on fertility among lupus nephritis patients in Saudi Arabia.

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Reproductive Biology and Fertility Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105420–105420
Publication date
25 March 2026
Language
EN